The Centre has told the Supreme Court that Indian missions all over the world have been working on a “war footing” for sourcing medicines like Amphotericin or additional and alternative drugs for the treatment of Covid related Mucormycosis (CAM) in the country.

The Union health ministry, in a 375- page affidavit filed in the apex court on Saturday, responded in detail to the query of an apex court bench about the steps being taken to ensure drug availability for Mucormycosis.

It said the projected production of LAmphotericin B by domestic manufacturers in August is likely to be 5.525 lakh units of injections and in order to maintain equitable distribution, states are given the medicines in accordance with the proportion of their reported caseload. Besides ramping up domestic production facilities of medicines like Amphotericin, the government said it has also issued guidance on the judicious use of the drug, and states and UTs have been required to put in place transparent arrangements for allocation to private and government hospitals.

“The drug Amphotericin is available both through domestic production and by imports, and both sources have been ramped up. The capacity and supply have had to be increased manifold in a very short period of time to cope with the surge in demand seen for the first time in May and June 2021.

These 3 factors can prevent delta plus variants from coming, experts said this

Vaccination for Kids: Zydus Cadila’s vax for kids above 12-yrs expected by August, NTAGI

Rajasthan CM writes to PM Moodi seeking his intervention for adequate supply of vaccines